The team focused on the mitochondrial calcium uniporter, or MCU, a channel protein embedded in the inner mitochondrial membrane that ferries calcium ions from the cytosol into the mitochondrial matrix. In mammals, the MCU complex includes pore-forming MCU proteins regulated by accessory components called MICU and EMRE, and decades of work have established that mitochondrial calcium homeostasis is essential for energy production, cell survival, and the decision between life and death. Plants possess their own family of MCU proteins: Arabidopsis carries six putative MCU orthologs, each with a conserved transmembrane domain, a pore loop, and a signature DVME sequence. Previous studies had shown that MCU1, MCU2, MCU3, and MCU5 localize to mitochondria, while MCU6 can target both mitochondria and chloroplasts, and that a triple mutant lacking MCU1, MCU2, and MCU3 shows reduced calcium uptake in roots. What remained unknown was what happens to the entire cell when this calcium gatekeeping system is disturbed.

To answer that question, the researchers first confirmed where the six MCU proteins reside and when they are active. Using fluorescent YFP tags in stable transgenic plants, they observed that the MCU proteins colocalize with mitochondrial markers in leaf and root cells. GUS staining revealed tissue-specific expression patterns: all six genes are active in the root stele, MCU3 is highly expressed in the root apex and cortex, MCU6 dominates the basal meristem, and MCU3, MCU4, and MCU6 are expressed in guard cells. This map of expression hinted that different MCU family members might play specialized roles in different tissues, but also that they share a common job as mitochondrial calcium channels.

The critical technical advance came from genetics. Because the six MCU genes are functionally redundant, the team crossed single mutants to build a sextuple knockdown line, mcu1-6, in which all six genes are expressed at reduced levels. They also created plants that massively overexpress MCU2, with one line showing a ninefold increase in transcript abundance. To watch calcium dynamics in real time, they targeted the calcium-sensitive luminescent reporter aequorin to the mitochondrial matrix and to the cytosol, then challenged seedlings with mannitol, which mimics drought-induced osmotic stress, and sodium chloride, which imposes salt stress. The results were unambiguous. Overexpressing MCU2 amplified the mitochondrial calcium surge, producing higher peak amplitudes and larger response curves, while the sextuple mutant blunted the response, reducing peak amplitudes by an average of 21 percent under mannitol and 26 percent under salt. Crucially, cytosolic calcium signals were unchanged in both lines, demonstrating that MCUs specifically tune mitochondrial calcium uptake without substantially buffering the cytosolic calcium wave that sweeps through stressed cells.

With the calcium phenotype established, the researchers turned to transcriptomics to see how the cell responds. They compared gene expression in the MCU2 overexpression line and the sextuple mutant against two reference conditions: untreated wild type and wild type treated with antimycin A, a drug that blocks the mitochondrial electron transport chain and classically induces the mitochondrial retrograde response. The comparison produced a surprise. Both MCU-perturbed genotypes activated a broad transcriptional program affecting mitochondrial proteostasis—genes encoding mitoribosomal proteins, oxidative phosphorylation complex subunits, the mitochondrial protein import machinery, and matrix proteases were all upregulated. Chaperone genes from four different compartments were induced as well: mitochondrial Hsp70 proteins, cytosolic chaperones, endoplasmic reticulum chaperones, and chloroplast chaperones. Western blots confirmed that mtHsp70 protein accumulated in the overexpression and knockdown lines. None of this multi-compartment chaperone induction appeared in antimycin-treated plants, and the alternative oxidase genes that normally mark the antimycin response stayed silent in the MCU mutants. In other words, disturbing mitochondrial calcium homeostasis triggers a stress program that is fundamentally different from the well-known retrograde response to respiratory chain damage.

The team interprets this pattern as the simultaneous activation of multiple compartment-specific unfolded protein responses. When proteins fail to fold properly in the mitochondrial matrix, the cell does not merely repair the mitochondrion; it appears to mobilize quality-control machinery in the cytosol, the ER, and the chloroplast as well. The researchers suggest that the underlying trigger is likely proteotoxic stress caused by disturbed mitochondrial translation. Supporting this idea, immunoblots showed that mitochondrially encoded subunits of respiratory complexes III, IV, and V—COB, COX1, ATP4, and ATP8—were reduced in the MCU-perturbed plants, while some nuclear-encoded subunits accumulated, creating a stoichiometric imbalance between the two genomes that supply the respiratory chain. This kind of mitonuclear protein imbalance is a classic activator of the mitochondrial unfolded protein response in animals, and the plant transcriptional profile resembled the interorganellar proteostasis program described in yeast, suggesting deep evolutionary conservation of this alarm system.

But the story did not end with transcription. Quantitative mass spectrometry of the proteome revealed that roughly half of the differentially abundant proteins in the sextuple mutant did not follow their transcript levels. Most strikingly, of the 194 cytosolic ribosomal protein genes whose abundance changed, about 58 percent showed reduced protein despite elevated mRNA. The same paradox appeared for chloroplast and mitochondrial ribosomal proteins and for pentatricopeptide repeat proteins, tetratricopeptide repeat proteins, and pseudouridine synthases—proteins that perform RNA editing and translation inside organelles. To investigate this apparent post-transcriptional repression, the researchers performed polysome profiling, separating actively translated mRNAs on polysomes from poorly translated ones on monosomes. While antimycin treatment caused a dramatic global shift from polysomes to monosomes, the MCU-perturbed plants showed only a mild global shift. Instead, translational efficiency analysis revealed a highly selective repression: genes involved in mitochondrial RNA metabolism and RNA modification lost translational efficiency in both the overexpression line and the sextuple mutant, with about 81 percent of RNA modification transcripts showing low translational efficiency. More than half of all transcriptionally induced cytosolic ribosomal protein mRNAs were also translationally repressed.

This selective translation program points to specific molecular effectors. In mammalian cells, the kinase GCN2 phosphorylates the translation initiation factor eIF2α to dampen protein synthesis during stress, while the TOR pathway senses energy status. The proteomic and immunoblot data told an unexpected tale: in the MCU-perturbed plants, eIF2α protein abundance and its phosphorylated form were both reduced, along with several translation initiation components, while TOR and the energy-sensing kinases KIN10 and KIN11 were largely unaffected. Antimycin treatment produced the opposite signature—increased KIN10 and KIN11 phosphorylation and reduced TOR, with no change in eIF2α. The authors propose that these two pathways mediate distinct types of mitochondrial stress: the TOR-S6K energy-sensing module handles the short-term, acute crisis caused by electron transport chain poisoning, whereas the eIF2α pathway manages the long-term, mild proteotoxic stress of chronic calcium imbalance. Counterintuitively, reducing eIF2α phosphorylation may be protective, preventing a catastrophic shutdown of protein synthesis during prolonged stress—an adaptive mechanism recently proposed in mammalian cells that now appears to operate in plants as well.

The physiological consequences of this molecular storm were visible to the naked eye. Plants with impaired MCU-controlled calcium homeostasis grew more slowly, with reduced leaf area that correlated with MCU2 expression levels in the overexpression lines. They also senesced prematurely, yellowing their older leaves weeks before wild type plants, and the timing of senescence tracked MCU2 dosage. Under osmotic stress induced by mannitol, both the overexpression lines and the sextuple mutant were significantly more sensitive than wild type, with markedly reduced fresh weight. These phenotypes establish a direct link between mitochondrial calcium homeostasis and the core stress biology traits of growth, aging, and stress resistance, and they suggest that the cross-compartmental proteostatic response is not merely a curiosity of gene expression but a determinant of plant fitness.

The study does have acknowledged limitations. The aequorin reporter lacks the sensitivity to resolve basal calcium levels or subtle changes after antimycin treatment, so modest differences in resting mitochondrial calcium cannot be excluded. The upstream regulators of MCU-mediated calcium signaling remain undefined, and future work with established calcium influx mutants such as osca and moca1 will be needed to position the uniporters within the broader calcium signaling hierarchy. The detailed molecular analysis also focused on a single high-expression MCU2 overexpression line, leaving open the possibility that individual MCU isoforms have distinct intrinsic activities. Even so, the findings provide a compelling new framework: mitochondrial calcium homeostasis, mitochondrial translation, and cellular proteostasis are woven together through an interconnected organelle quality control network that integrates transcriptional activation with selective translational repression. As climate change intensifies drought and salinity stress on crops, understanding and potentially engineering this calcium-triggered proteostatic alarm could offer new genetic targets for breeding more resilient plants.

Subject of Research: Mitochondrial calcium homeostasis and cross-compartmental proteostatic signaling in Arabidopsis

Article Title: Perturbation of mitochondrial Ca2+ homeostasis activates cross-compartmental proteostatic response in Arabidopsis

Article References: Perturbation of mitochondrial Ca2+ homeostasis activates cross-compartmental proteostatic response in Arabidopsis. (n.d.). https://doi.org/10.1007/s44154-026-00314-4

Image Credits: AI Generated

DOI: 10.1007/s44154-026-00314-4

Keywords: mitochondria, calcium signaling, mitochondrial calcium uniporter, Arabidopsis, unfolded protein response, proteostasis, retrograde signaling, eIF2α, translation regulation, plant stress, ribosomal proteins, senescence

The researchers set out to answer a question that has shadowed addiction neuroscience for decades: what allows drugs to drive dopamine release at intensities that ordinary rewards never reach? Their hypothesis centered on energy. Dopamine terminals in the nucleus accumbens are extraordinarily metabolically demanding structures, packed with mitochondria positioned near active zones where vesicles of dopamine await release signals. When dopaminergic neurons fire at high frequency, the energy demands of packaging, mobilizing, and releasing vesicles can outstrip local ATP supplies. Previous work had established that presynaptic mitochondria buffer calcium and synthesize ATP on demand, but whether this mitochondrial machinery was specifically recruited during drug reward—rather than reward in general—remained unknown.

To watch mitochondrial calcium in real time, the team used a genetically encoded fluorescent indicator called 4mt-jGCaMP8s, targeted to the mitochondrial matrix, expressed selectively in dopaminergic neurons of mice. Using fiber photometry, they monitored calcium signals from dopaminergic terminals in the nucleus accumbens while animals received heroin, morphine, methamphetamine, or cocaine. The results were unambiguous: heroin and methamphetamine produced robust, rapid mitochondrial calcium transients in accumbal dopamine terminals, while cocaine did not. This selectivity held up under two-photon imaging with a head-mounted microscope in freely moving animals, and the signal was strongest in the core of the nucleus accumbens, a subregion closely tied to drug seeking. Critically, when animals consumed natural rewards such as sucrose, the same terminals showed no comparable mitochondrial calcium influx.

The gateway for this calcium was identified as the mitochondrial calcium uniporter, or MCU, a channel in the inner mitochondrial membrane that was molecularly identified more than a decade ago. MCU allows calcium to flow down its steep concentration gradient into the mitochondrial matrix, where it activates calcium-sensitive enzymes of the tricarboxylic acid cycle and stimulates oxidative phosphorylation. In essence, mitochondrial calcium influx is how a mitochondrion learns that its host cell is working hard and needs more fuel. The Beijing team confirmed that the drug-evoked signals depended on MCU: in dopaminergic neurons lacking the uniporter, or in neurons treated with the MCU inhibitors Ru360 and berberine, the drug-induced mitochondrial calcium rise was abolished, while cytoplasmic calcium responses to the drugs remained intact.

Why would drugs, but not natural rewards, engage this pathway? The answer emerged from optogenetic experiments in which the researchers artificially drove dopaminergic terminals at defined frequencies. At low stimulation frequencies of around 4 hertz, mimicking the modest firing rates associated with physiological rewards, mitochondrial calcium barely moved, and deleting MCU had no effect on evoked dopamine release. But at 20 and 40 hertz—intensities characteristic of drug-evoked activation—mitochondrial calcium influx became prominent, and its absence sharply reduced dopamine release measured with the GRAB_DA2m fluorescent sensor. The conclusion is elegant: MCU-mediated mitochondrial calcium is recruited only when dopaminergic neurons are pushed beyond their normal metabolic comfort zone, which is precisely the regime that addictive drugs occupy and that natural rewards do not.

The mechanism linking calcium to release proved to be energy. Using the genetically encoded ATP sensor ATeam1.03 targeted to mitochondria, the researchers showed that drug-like high-intensity stimulation drove a rapid rise in mitochondrial ATP production that required MCU. When they blocked ATP synthesis with oligomycin, or supplied exogenous ATP to neurons lacking MCU, the picture sharpened further: ATP replenishment rescued the vesicle release deficit in MCU-deficient neurons, while ATP depletion mimicked it. Probing the vesicle machinery directly with a pHluorin-tagged vesicular monoamine transporter, the team found that the readily releasable pool of dopamine vesicles was depleted in MCU knockout neurons, and that this deficit was restored by ATP supplementation. In other words, the mitochondrial calcium influx does not directly trigger release; it manufactures the ATP that keeps the release machinery stocked during metabolically punishing bursts of activity.

The behavioral consequences were decisive. Mice engineered to lack MCU specifically in dopaminergic neurons showed dramatically reduced locomotor responses to heroin and morphine, blunted conditioned place preference for opioids, and diminished cue-induced reinstatement of cocaine seeking after extinction—a laboratory model of relapse. Circuit-specific deletion confirmed the anatomy: removing MCU only from dopaminergic neurons projecting from the ventral tegmental area to the nucleus accumbens impaired heroin reward, whereas deletion in the projection to the prefrontal cortex did not. Pharmacological validation followed. Berberine, a natural compound recently characterized as an MCU inhibitor that disrupts the channel’s assembly with its regulatory partner EMRE, reduced mitochondrial calcium uptake in cultured dopaminergic neurons, attenuated heroin conditioned place preference when microinjected into the nucleus accumbens, and suppressed cue-induced reinstatement of cocaine seeking when given systemically.

Perhaps most striking is what did not happen. Mice lacking MCU in dopaminergic neurons performed indistinguishably from controls across a battery of tests probing dopamine-dependent physiology: spontaneous locomotion, working memory in the Y-maze, anxiety-like behavior, despair-related immobility, sucrose preference, motor coordination on the rotarod, and spatial learning in the Morris water maze. Food-conditioned place preference, a model of natural reward learning, was preserved. Whole-brain MCU knockout mice, generated with Nestin-Cre, developed normally with expected Mendelian ratios and showed no deficits in dopamine-related behaviors. The therapeutic window implied by these results is unusually wide: the bioenergetic pathway appears to be dispensable for everyday reward processing yet essential for the supraphysiological dopamine output that drugs commandeer.

The study reframes addiction as, in part, a metabolic disease of synapses. Drugs of abuse differ in their molecular targets—opioids bind receptors, methamphetamine reverses transporters, cocaine blocks reuptake—but they converge on a common output: high-intensity dopaminergic activation in the accumbens. This work shows that convergence extends to the mitochondria, which are forced into emergency ATP production to sustain the pathological signal. By targeting MCU, or the calcium-driven bioenergetics it enables, it may be possible to starve the addictive circuitry of its energy supply while leaving the mitochondria of ordinary reward signaling untouched. Considerable distance remains between mouse models and human therapy, and berberine’s properties as a drug candidate will need rigorous evaluation. But the identification of a drug-selective mitochondrial mechanism offers something addiction research has rarely possessed: a molecular distinction between the dopamine that fuels compulsion and the dopamine that fuels life.

Subject of Research: Mitochondrial calcium uniporter-mediated bioenergetics in dopaminergic terminals that selectively enable drug-induced dopamine release and addictive behavior

Article Title: Mitochondrial calcium influx-driven bioenergetics selectively enable drug addiction

Article References: Gao, J., Zhao, H., Han, X., Zeng, L., Pan, J., Liu, G., Wei, X., Liu, C., Wu, W., Chen, S., Chen, J., Li, T., Yin, J., Zhou, T., Zhang, X.-M., Li, A.-L., Li, T., & Pan, X. (2026). Mitochondrial calcium influx-driven bioenergetics selectively enable drug addiction. Nature Neuroscience. https://doi.org/10.1038/s41593-026-02421-x

Image Credits: AI Generated

DOI: 10.1038/s41593-026-02421-x

Keywords: addiction, mitochondria, mitochondrial calcium uniporter, dopamine, nucleus accumbens, reward, MCU, bioenergetics, opioids, methamphetamine, ATP, berberine